MSF concerned about access to drugs in Guatemala

Document Type

Article

Department

Ophthalmology

Abstract

Médecins Sans Frontières (MSF) has welcomed the repeal of a Guatemalan law that restricted access to medicines in the country, but warned that provisions included in the US—Central American Free Trade Agreement (CAFTA) could undermine the benefits of this repeal. “CAFTA will have a very serious impact on access to medicines because it will effectively prevent a generic drug being registered for use within 5 years of the registration of the originator product”, warned Ellen't Hoen, from MSF's Campaign for Access to Essential Medicines.

Publication (Name of Journal)

Lancet infectious diseases

Share

COinS